SAFE-BioPharma named Computerworld Laureate
SAFE-BioPharma, the global digital identity and digital signature standard for the life sciences and healthcare sectors, has been named a 2012 Computerworld Laureate.
IDG’s Computerworld Honors Program, which recognizes visionary applications of information technology promoting positive social, economic and educational change, has recognized the SAFE-BioPharma standard for its role in facilitating cloud-based collaboration between National Cancer Institute researchers and their private sector counterparts to accelerate initiation of a cancer clinical trial while lowering its costs and reducing paper-reliance.
The public and private cancer researchers were provisioned with interoperable digital identities, a form of software installed on a computer, cell phone or other device, which establishes a close link with the user's proven identity and allows for the application of digital signatures to electronic documents. Unlike simple electronic signatures, digital signatures cryptographically guarantee the integrity of documents to which they are affixed. In the pilot study, the electronic documents were placed in the cloud, where the researchers were able to access, sign, and exchange them immediately. Prior to the study, the signature process was delayed by travel and the use of courier, fax, etc.
The 2012 Computerworld Laureates will be recognized publicly at the laureate medal ceremony and gala evening on June 4 in Washington, D.C.